So, B-Vaxx not dead at all.
We got now 2 vaxx in the trials with HerVaxx already outperforming anything available at relevant developing stages and now we learn that even B-Vaxx, developed before HerVaxx, is showing fantastic results compared to the T-cell products. And to top that, the even more advanced KeyVaxx is to hit the clinics soon. And a MC of just 60m including at least 15m in cash, assuming some has been spent since December from the 20m plus.
Sp today 1.5c due to excellent news, ASX morons, come on, let's crash it lower.
Ann: Clinical Cancer Research Journal publish B-Vaxx Phase 1 Data, page-3
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.002(5.41%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 4.0¢ | 3.5¢ | $1.163M | 31.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 2275218 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 196677 | 3 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
